University of California Los Angeles Selects Velos eresearch
The News Review:
- University of California Los Angeles Selects Velos eresearch
- Hoy to open new research centre
- Scottsdale Healthcare study helps target cancer treatment
- invivodata Certified to Deliver EXACT in CPD Trials
- Revised Clinical Trial Principles Reinforce PhRMA’s Commitment
- » Clinical Research Associate II
University of California Los Angeles Selects Velos eresearch
SunHerald.com (press release)
The clinical research management system is being implemented at UCLA's Jonsson Comprehensive Cancer Center and an affiliated clinical research network Translational ncology Research International (TRI). Plans are in place to deploy the system in non-cancer studies being conducted in the David Geffen School of Medicine at UCLA.
Hoy to open new research centre
BBC News
"It is a wonderful example of how the wider community can support the work of our doctors nurses and researchers looking at making things better. " ‘State of the art’Previous research has taken place in the hospital’s open wards but the new two-bedded facility and consulting room will mean children taking part in trials are in private environment. Professor Robert Minns of Edinburgh University who has led the development of the unit said: "Clinical research is pivotal for advancing the way we treat patients and manage diseases. "This unit will bring together all research projects involving children in a dedicated area with experienced staff and state of the art equipment in a children’s hospital environment. " Grant Macrae chairman of the Sick Kids Friends Foundation said: "This excellent new facility is a good example of how our fundraising directly helps sick children. "We hope clinical research goes from strength to strength with the aid of this new facility adding to our knowledge and understanding about important childhood illnesses and supporting improved treatment. " Bookmark with:.
Scottsdale Healthcare study helps target cancer treatment
AZ Central.com
All the patients had late-stage cancers and had anywhere from two to six previous treatments. “It also tells you what kind of treatment is not likely to be helpful for you. And treatments can have some pretty nasty side effects” said Slater also head of the Scottsdale Clinical Research Institute. “And the longer we wait trying treatments that are not effective the more the disease progresses. The clinical studies were conducted at the Virginia G. Piper Cancer Center at Scottsdale Healthcare Shea Medical Center. Principal investigator was Dr.
Related from Acnemonster: TopoTarget reports Phase II trial results with Avugane
invivodata Certified to Deliver EXACT in CPD Trials
PR Newswire (press release)
5: Blog it chicklet ends here –> invivodata Certified to Deliver EXACT in CPD Trials. the industry leader in electronic Patient-Reported utcomes (ePR) solutions and services for global clinical research today announced that it has completed a certification program to provide the EXAcerbations of Chronic pulmonary disease Tool (EXACT) on its DiaryPR(C) field-based ePR system. The EXACT is a Patient-Reported utcome (PR) measure for evaluating the frequency severity and duration of acute exacerbations of chronic obstructive pulmonary disease (CPD) and chronic bronchitis (AECB) in international clinical trials. Developed by United BioSource Corporation’s (UBC) Center for Health utcomes Research with significant input from clinical and instrument development experts and involvement of the U. Food and Drug Administration (FDA) the EXACT is the industry’s only standardized tool for measuring exacerbations of CPD.
Revised Clinical Trial Principles Reinforce PhRMA’s Commitment
Pharmaceutical nline (press release)
“But we’ve heard the calls that we could do more. And these revised Principles which come on the heels of our updated Code on Interactions With Healthcare Professionals further renew our pledge to ?practice what we preach. ‘”"We hope that all companies that sponsor clinical research and publish results on websites and in peer-reviewed journals will adopt these standards” Tauzin added. The PhRMA Principles on Conduct of Clinical Trials and Communication of Clinical Trial Results (read the report) which take effect on ctober 1 2009 fortify our commitment to patients and healthcare professionals by increasing transparency in clinical trials enhancing standards for medical research authorship and improving disclosure to manage potential conflicts of interest in medical research. Among its changes the revised Principles: Increase transparency by committing companies to the timely registration of all interventional clinical trials involving patients – including some early Phase 1 studies – on a public website to help patients who need medical care enroll in relevant studies. There are important public health benefits associated with making appropriate clinical trial information widely available to healthcare practitioners patients and others. The most important clinical trials are those that test a medicine in patients -people who actually require medical care.
» Clinical Research Associate II
Hays Pharma
00 per annumLocationCzech Republic23 Apr 2009Completes project activities associated with monitoring functions of Phase I-IV clinical research studies while developing an understanding of the drug development process Good Clinical Practices and relevant regulations. Provide clinical and technical support for CRA I and administrative staff. Performs management of study site activities to ensure the integrity of clinical data in adherence to all applicable regulatory guidelines and Standard perating Procedures (SPs) and Project Specific perating Procedures (PSPs). May assume the role of a Lead CRA on projects by providing direction and guidance to the project team coordinating all monitoring activities and communicating the status of these activities to the study Project Leader. CRE RESPNSIBILITIES Performs clinical trial initiation monitoring and close out activities.
Written by admin on April 23rd, 2009 with
no comments.
Read more articles on News.